These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 1378133

  • 1. Beta-blocking agents with vasodilating action.
    Prichard BN.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S1-4. PubMed ID: 1378133
    [Abstract] [Full Text] [Related]

  • 2. Clinical pharmacology of multiple action compounds.
    Prichard BN, Tomlinson B.
    Z Kardiol; 1989; 78 Suppl 3():1-6. PubMed ID: 2573211
    [Abstract] [Full Text] [Related]

  • 3. Progress in antihypertensive therapy with a multiple-action drug.
    Prichard BN, Tomlinson B.
    Drugs; 1988; 36 Suppl 6():20-5. PubMed ID: 2908301
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Beta-blocking agents with vasodilator activity.
    Rosendorff C.
    J Hypertens Suppl; 1993 Jun; 11(4):S37-40. PubMed ID: 8104240
    [Abstract] [Full Text] [Related]

  • 6. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
    Lund-Johansen P, Omvik P.
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
    [Abstract] [Full Text] [Related]

  • 7. Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta 2 agonist-mediated vasodilation and beta antagonism.
    Sybertz EJ, Watkins RW.
    Am J Cardiol; 1989 Jun 05; 63(19):3I-6I. PubMed ID: 2567112
    [Abstract] [Full Text] [Related]

  • 8. Actions of dilevalol on adrenoceptors.
    Louis WJ, Drummer OH, Tung LH.
    J Cardiovasc Pharmacol; 1988 Jun 05; 11 Suppl 2():S5-11. PubMed ID: 2464095
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol.
    Lund-Johansen P.
    J Cardiovasc Pharmacol; 1988 Jun 05; 11 Suppl 2():S12-7. PubMed ID: 2464093
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ, McNeil JJ, Drummer OH.
    Drugs; 1984 Jun 05; 28 Suppl 2():16-34. PubMed ID: 6151889
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacology of vasodilatory beta-blocking drugs.
    Shanks RG.
    Am Heart J; 1991 Mar 05; 121(3 Pt 2):1006-11. PubMed ID: 1671724
    [Abstract] [Full Text] [Related]

  • 12. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC, McKaigue JP, Guy S, Shanks RG, Riddell JG.
    Br J Clin Pharmacol; 1993 Sep 05; 36(3):251-6. PubMed ID: 9114912
    [Abstract] [Full Text] [Related]

  • 13. Pharmacodynamic profile of carvedilol.
    van Zwieten PA.
    Cardiology; 1993 Sep 05; 82 Suppl 3():19-23. PubMed ID: 8106159
    [Abstract] [Full Text] [Related]

  • 14. Interaction between alpha- and beta-adrenoceptor-mediated cardiovascular effects.
    van Zwieten PA.
    J Cardiovasc Pharmacol; 1986 Sep 05; 8 Suppl 4():S21-8. PubMed ID: 2427848
    [Abstract] [Full Text] [Related]

  • 15. Vasodilatory action of carvedilol.
    Sponer G, Strein K, Bartsch W, Müller-Beckmann B.
    J Cardiovasc Pharmacol; 1992 Sep 05; 19 Suppl 1():S5-11. PubMed ID: 1378150
    [Abstract] [Full Text] [Related]

  • 16. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
    Watkins RW, Sybertz EJ, Cook J, Pula K, Cedeno K, Tedesco RP, McLeod R.
    Arch Int Pharmacodyn Ther; 1989 Sep 05; 302():158-73. PubMed ID: 2576892
    [Abstract] [Full Text] [Related]

  • 17. Haemodynamic effects of new beta-blockers with vasodilatory properties in essential hypertension.
    Tsukiyama H, Otsuka K, Horii M.
    Drugs; 1988 Sep 05; 36 Suppl 6():48-54. PubMed ID: 2908304
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive compounds with combined actions.
    Rahn KH.
    J Cardiovasc Pharmacol; 1987 Sep 05; 10 Suppl 11():S18-22. PubMed ID: 2454363
    [Abstract] [Full Text] [Related]

  • 19. Vasodilating beta-adrenoceptor blocking drugs do not redistribute myocardial flow during acute coronary ligation in dogs.
    Berdeaux A, Bonhenry C, Giudicelli JF.
    Eur J Pharmacol; 1985 Jun 19; 112(3):379-85. PubMed ID: 2862054
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.